Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
The Israel Medical Association Journal : IMAJ|June 23, 2022
Cannabis and Autoimmune DiseasesShir Rubinstein Levy, Gilad Halpert, Howard AmitaAutoimmunity Reviews|August 26, 2014
The effect of the novel tellurium compound AS101 on autoimmune diseasesGilad Halpert, Benjamin SredniHarefuah|September 21, 2020
[SILICONE BREAST IMPLANTS - HISTORICAL MEDICAL ERROR]Gilad Halpert, Howard Amital, Yehuda ShoenfeldThe Israel Medical Association Journal : IMAJ|April 2, 2025
Cannabidiol and Its Effects on Patients with COVID-19 InfectionYuval Kuntzman, Gilad Halpert, Howard AmitalHarefuah|June 17, 2024
[THE MUSCULAR COMPONENT OF FIBROMYALGIA PATHOPHYSIOLOGY]Daniel Yechiali, Liel Katbi, Gilad Halpert, et al.Journal of Inflammation (London, England)|March 9, 2010
The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophagesMiri Brodsky, Gilad Halpert, Michael Albeck, et al.Dermatology (Basel, Switzerland)|December 8, 2022
New-Onset Guttate Psoriasis: A Long-Term Follow-Up StudyEran Galili, Shir Rubinstein Levy, Ido Tzanani, et al.Autoimmunity Reviews|September 4, 2025
Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disordersInbar Michaeli, Simon Lassman, Gilad Halpert, et al.Autoimmunity Reviews|February 21, 2021
The SARS-CoV-2 as an instrumental trigger of autoimmunityArad Dotan, Sylviane Muller, Darja Kanduc, et al.Clinical Reviews in Allergy & Immunology|July 28, 2023
Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in AutoimmunityYekbun Adiguzel, Naim Mahroum, Sylviane Muller, et al.Pageof 5